Nerve Growth Factor Activation of Erk-1 and Erk-2 Induces Matrix Metalloproteinase-9 Expression in Vascular Smooth Muscle Cells

This publication has 36 references indexed in Scilit:

• Selective Activation of MAPKerk1/2 by Laminin-1 Peptide α1:Ser2091–Arg2108 Regulates Macrophage Degradative Phenotype
  Journal of Biological Chemistry, 2000
• Hyperplasia in multiple smooth muscle tissues in transgenic mice expressing a temperature-sensitive SV40 T-antigen under the control of smooth muscle alpha-actin regulatory sequences
  Oncogene, 1999
• Editorial
  Cardiovascular Research, 1999
• Synergistic upregulation of metalloproteinase‐9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF‐κB
  FEBS Letters, 1998
• Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line
  Oncogene, 1997
• Identification of an essential nonneuronal function of neurotrophin 3 in mammalian cardiac development
  Nature Genetics, 1996
• Early events in neurotrophin signalling via Trk and p75 receptors
  Current Opinion in Neurobiology, 1995
• A Novel Nerve Growth Factor-responsive Element in the Stromelysin-1 (Transin) Gene That Is Necessary and Sufficient for Gene Expression in PC12 Cells
  Published by Elsevier ,1995
• Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.
  Journal of Clinical Investigation, 1994
• NGF induction of the gene encoding the protease transin accompanies neuronal differentiation in PC12 cells
  Neuron, 1989